PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer

Summary

This Phase 1 trial will evaluate the safety and tolerability of PSA-Activated PSA-PAH1 in subjects who have shown biochemical failure and have either completed at least one primary radiation therapy for prostate cancer and have evidence of recurrent local prostate cancer without metastases.

Timeline

Start

2006-03

Primary completion

2007-05

Completion

2008-07

Drugs

Indications